Key Takeaways: From Dr. Prince Uchadiya’s Clinical Experience in Indore

  • Rheumatoid arthritis in India has an estimated prevalence of 0.7%, higher than the global average of 0.46%, and affects women 2 to 3 times more often than men. PMC Central India RA Study
  • The most dangerous thing about RA is the diagnostic delay. In India, the median time from symptom onset to starting disease-modifying treatment is 3 years. In those 3 years, irreversible bone and cartilage erosion is already happening. Early diagnosis and early DMARD therapy changes the entire trajectory of the disease.
  • 84% of patients in an India RA cohort had moderate to high disease activity at their first specialist visit. By 3 months of structured DMARD therapy, that figure fell to under 2%. PMC India RA Outcomes Study
  • Orthopaedic surgery plays a critical role in RA when joints are already damaged. Knee replacement, hip replacement, and shoulder replacement in RA patients are among the most functionally transformative procedures I perform, particularly because these patients have often suffered for many years before reaching this point.
  • RA is not only a hand and wrist disease. The knee, hip, ankle, cervical spine, and shoulder are all commonly affected, and in many patients the large joint involvement is the presenting or dominant problem.
  • Methotrexate combined with hydroxychloroquine is the most commonly used DMARD combination in India, producing significant disease activity reduction when used correctly. PubMed India RA Treatment Study
  • The orthopaedic and medical management of RA must work together. The rheumatologist controls the disease. The orthopaedic surgeon repairs the damage the disease has already caused. Neither alone is sufficient for patients with advanced joint involvement.

What Rheumatoid Arthritis Actually Is

Rheumatoid arthritis is a chronic autoimmune disease. The immune system, which is supposed to attack bacteria and viruses, mistakenly targets the synovial membrane lining of joints. This produces persistent inflammation in the joint lining, progressive erosion of cartilage and bone, and over time, structural joint destruction and deformity. Unlike osteoarthritis, which is a mechanical wear problem, RA is a systemic inflammatory disease that affects the entire body, not just the joints. Fatigue, anaemia, cardiovascular risk, lung involvement, and eye inflammation are all recognised manifestations of inadequately controlled RA.

The joint pattern in RA is characteristically symmetrical. Both wrists, both hands, both knees, both ankles, both feet tend to be affected. The small joints of the hands and feet are typically involved early. The metacarpophalangeal joints, the proximal interphalangeal joints, and the wrists are the classic early targets. But the knee, hip, shoulder, elbow, and cervical spine are frequently involved as the disease progresses or in patients with more aggressive disease from the outset.

What makes early diagnosis and treatment so critical is that joint erosion begins within weeks to months of disease onset. Cleveland Clinic data confirms that without adequate treatment, RA causes permanent joint damage in the majority of patients within 2 years of onset. The window for preventing structural damage is real and it is narrow.

Who Develops RA and Why: The Indore Patient Profile

RA most commonly develops between the ages of 30 and 60, and women are affected 2 to 3 times more often than men. In the clinic in Nipania, Indore, the typical first presentation is a woman in her 30s or 40s with bilateral hand and wrist pain that is worst in the morning, takes more than an hour to loosen up, and is accompanied by fatigue that she often attributes to anaemia or stress. She has frequently been managing with painkillers for months before the diagnosis is considered.

The triggers for RA are not fully understood. Genetic susceptibility, particularly the HLA-DR4 haplotype, creates the background risk. Environmental triggers including smoking, which is one of the strongest modifiable risk factors for RA, hormonal factors, and possibly gut microbiome changes activate the autoimmune response in susceptible individuals. In India, where RA prevalence is estimated at 0.7%, slightly above the global average, the combination of genetic predisposition and environmental factors produces a significant burden of disease that is compounded by diagnostic delay.

Patients from across Indore and Madhya Pradesh, including from Vijay Nagar, Scheme 54, Palasia, and surrounding districts, attend the clinic both for initial assessment and for surgical management of established joint damage. The orthopaedic consultation is most commonly needed when large joint involvement, particularly the knee or hip, is either the dominant presenting problem or has developed despite otherwise controlled disease.

Recognising RA: Symptoms That Should Trigger Urgent Assessment

The symptoms of active RA are specific enough to recognise clinically before blood tests confirm the diagnosis. Morning stiffness lasting more than 60 minutes that improves with movement and warmth is one of the most discriminating features. Bilateral, symmetrical swelling and tenderness in the small joints of the hands and feet, particularly the knuckle joints and the joints at the base of the fingers, is the classic early pattern.

Systemic features including persistent fatigue disproportionate to activity level, unintentional weight loss, low-grade fever, and anaemia accompany active joint inflammation. These are not coincidental. They reflect the systemic inflammatory state that characterises RA and distinguishes it from a purely mechanical joint problem.

When RA is not diagnosed or treated early, the joints begin to deform. The characteristic ulnar drift of the fingers, the swan neck and boutonniere deformities of the finger joints, and the Z-deformity of the thumb develop from persistent synovial inflammation and gradual tendon and ligament destruction. These deformities are not cosmetic concerns. They represent irreversible structural damage that significantly impairs hand function. The same erosive process in the knee causes progressive cartilage loss, joint line tenderness, and effusion that mirrors the presentation of knee osteoarthritis in Indore, though the underlying mechanism and systemic context are different.

How Rheumatoid Arthritis Is Diagnosed in Indore

Diagnosis combines clinical assessment, blood tests, and imaging. No single test confirms RA. The 2010 ACR/EULAR classification criteria use a scoring system based on joint involvement, serology, inflammatory markers, and symptom duration.

  1. Clinical examination: Symmetrical joint swelling and tenderness, morning stiffness duration, and the specific joints involved are assessed. The examination also looks for rheumatoid nodules, which are firm lumps under the skin near pressure points, and for extra-articular features including eye inflammation and lung signs.
  2. Blood tests: Rheumatoid factor (RF) is positive in approximately 70 to 80% of RA patients. Anti-CCP (anti-cyclic citrullinated peptide) antibody is more specific for RA and is positive in similar proportions. Both negative does not exclude RA; seronegative RA is a recognised entity. CRP and ESR measure the degree of systemic inflammation and are used to monitor disease activity and treatment response. A full blood count typically shows anaemia of chronic disease in active RA.
  3. X-ray: Weight-bearing X-rays of the hands, wrists, and any large joints involved. Early RA shows periarticular osteoporosis and soft tissue swelling. Established disease shows joint space narrowing and bone erosions at the joint margins, the hallmark of inflammatory joint destruction.
  4. MRI and ultrasound: MRI is the most sensitive imaging modality for detecting early synovitis, bone marrow oedema, and erosions before they are visible on X-ray. Musculoskeletal ultrasound allows dynamic assessment of joint and tendon sheath synovitis and can be used to guide diagnostic joint aspiration.

Rheumatoid Arthritis Treatment in Indore: The Full Management Pathway

Medical Management: The Foundation

The medical treatment of RA is managed by a rheumatologist and is the essential foundation on which everything else builds. Orthopaedic management of joint damage is only effective when the underlying disease is controlled. Operating on a joint while RA remains active accelerates the erosive damage in adjacent structures and compromises implant and tissue healing.

  1. NSAIDs for symptom control: Non-steroidal anti-inflammatory drugs reduce pain and stiffness in the short term but do not slow joint erosion. They are used as adjuncts, not as primary treatment. Gastrointestinal protection with a proton pump inhibitor is standard when NSAIDs are used long-term.
  2. Corticosteroids: Low-dose oral prednisolone or short courses of injectable methylprednisolone rapidly suppress acute flares and provide a bridge to effective DMARD therapy. They are not a long-term solution because of their cumulative side effects including bone loss, which compounds the osteoporosis already driven by RA itself.
  3. Conventional DMARDs: These are the cornerstone of RA treatment. Methotrexate is the anchor DMARD for most patients. It is typically combined with hydroxychloroquine and sometimes leflunomide or sulfasalazine in a dual or triple DMARD regimen. Indian clinical data from a central India tertiary centre shows that structured dual DMARD therapy, most commonly methotrexate-hydroxychloroquine, reduces high disease activity from 23% at baseline to under 2% at 3 months. This is the treatment that changes the trajectory of the disease when started early.
  4. Biologic DMARDs: For patients who fail conventional DMARDs, biologic agents targeting specific inflammatory pathways are the next step. TNF-alpha inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), and T-cell co-stimulation blockers (abatacept) are the main classes. They are significantly more expensive than conventional DMARDs and less widely used in India currently, but they represent the most effective medical treatment available for refractory disease.
  5. JAK inhibitors: Targeted synthetic DMARDs including tofacitinib and baricitinib are oral agents that inhibit the JAK-STAT inflammatory signalling pathway. They are used when conventional DMARDs and biologics have been inadequate.

The Orthopaedic Role: When Surgery Is Part of the Plan

Surgery in RA is not a failure of medical management. It is a complementary component of care for patients in whom joint damage has already occurred beyond what medication can reverse, or in whom a specific joint is causing functional limitation that medical treatment alone cannot address. The decision to operate is made collaboratively, with the rheumatologist confirming that disease is adequately suppressed before surgery proceeds.

  1. Knee replacement in RA: The knee is one of the most commonly affected large joints in RA and frequently requires replacement when cartilage is destroyed. Patients with RA undergoing total knee replacement require careful perioperative planning, including medication adjustment around the time of surgery to balance infection risk and wound healing against disease flare. The outcomes of knee replacement in RA patients are generally excellent when disease is controlled. More information on this procedure is on the knee replacement surgery page.
  2. Hip replacement in RA: RA-related hip destruction is less common than knee involvement but produces severe functional limitation when it occurs. Hip replacement in RA is technically similar to primary osteoarthritis cases but requires attention to bone quality, which may be reduced from the disease itself and from long-term corticosteroid use. Details of the procedure are on the hip replacement surgery page.
  3. Shoulder replacement in RA: RA is one of the leading causes of shoulder joint destruction requiring replacement. The rotator cuff tendons, which are critical for shoulder function, are frequently damaged by RA synovitis. This affects the choice between standard and reverse shoulder replacement. The shoulder replacement surgery page covers this in more detail.
  4. Synovectomy: Arthroscopic removal of the inflamed synovial tissue from a joint before structural damage has occurred can slow progression and reduce pain in a specific joint that is not adequately controlled by medication alone. It is most commonly performed in the knee. The arthroscopy surgery page outlines the arthroscopic approach used at the clinic.
  5. Tendon repair and reconstruction: RA-related tendon ruptures, particularly in the hand and wrist, require surgical repair or reconstruction to restore function. These are specialised procedures performed in conjunction with hand surgery expertise.
  6. Foot and ankle surgery: The foot and ankle are frequently affected in RA, producing deformity, pain, and difficulty walking. Fusion of affected hindfoot and midfoot joints and correction of forefoot deformities are procedures that significantly improve walking ability. The broader context of foot and ankle arthritis management is covered on the ankle and foot arthritis treatment page.

Living with RA: What Patients in Indore Need to Know Long-Term

RA is a lifelong condition that requires long-term management. It does not resolve. Periods of low disease activity, called remission, are the treatment goal. Modern DMARD therapy achieves remission in a substantial proportion of patients, particularly when started early. During remission, joint damage stops progressing, function is maintained, and quality of life is near-normal.

Structured physiotherapy and hand therapy maintain joint mobility and muscle strength during and between flares. Post-injury rehabilitation at the clinic supports patients in maintaining function after orthopaedic procedures. Smoking cessation is the single most impactful lifestyle modification for RA patients, as smoking worsens disease activity, reduces treatment response, and independently increases cardiovascular risk.

Patients with RA are at elevated cardiovascular risk from the systemic inflammatory burden and require monitoring and management of blood pressure, lipids, and glucose. Osteoporosis is accelerated by both RA itself and by corticosteroid use, making bone density assessment and protective therapy important components of ongoing care.

For patients who have already been diagnosed and are seeking clarification on their joint damage, surgical options, or a management plan that has not been achieving adequate control, a structured orthopaedic second opinion at Dr. Prince Uchadiya’s Nipania clinic provides a specialist assessment of both the joint status and the surgical options relevant to the clinical picture.

Frequently Asked Questions: Rheumatoid Arthritis Treatment in Indore

1. Is rheumatoid arthritis curable?

No. RA is a chronic autoimmune condition without a definitive cure. The treatment goal is sustained remission, a state of minimal or no active disease, in which joint damage stops progressing and function is maintained. Modern DMARD therapy achieves remission in many patients, particularly when treatment begins early. Some patients maintain remission with reduced medication over time, but stopping treatment entirely usually leads to disease recurrence.

2. How is rheumatoid arthritis different from normal joint arthritis?

Osteoarthritis is mechanical wear and tear of cartilage, affecting typically older patients in weight-bearing joints. RA is an autoimmune disease that produces inflammatory erosion of multiple joints simultaneously, affects younger people including those in their 30s and 40s, is symmetrical in distribution, comes with systemic features like fatigue and anaemia, and if untreated causes a distinctly different pattern of joint destruction with erosions visible on X-ray at the joint margins rather than central joint space loss.

3. Can the joint damage from RA be reversed?

Bone and cartilage that has been eroded by active RA does not regenerate. The damage is structural and permanent. What effective DMARD therapy achieves is halting further damage. For joints where damage has progressed to the point of severe functional limitation, orthopaedic surgery, including joint replacement or fusion, replaces or stabilises the destroyed joint and restores function. Surgery does not reverse the disease, but it addresses the consequence of the damage already done.

4. I have morning stiffness in my hands for over an hour. Should I be worried?

Morning stiffness lasting more than 60 minutes, particularly in the small joints of both hands symmetrically, is one of the most characteristic features of inflammatory arthritis including RA. It warrants prompt assessment. This is different from the brief stiffness that resolves within 15 to 20 minutes that is typical of osteoarthritis. Get blood tests including rheumatoid factor, anti-CCP antibody, CRP, and ESR done and see a specialist. Early RA identified at this stage responds dramatically better to treatment than disease that has already produced erosions.

5. My knee is very swollen. Can RA affect the knee alone?

Yes. While RA classically presents with small joint involvement first, large joint involvement including the knee is common and sometimes the dominant presentation. A knee that is warm, swollen, and stiff bilaterally in a younger patient with morning stiffness and fatigue is a clinical picture that warrants RA evaluation rather than assuming the cause is mechanical knee arthritis. A clinical examination and blood tests will direct the diagnosis. For more on knee arthritis management see the knee arthritis treatment page.

6. Do I need surgery for RA, or can it always be managed with medication?

Most patients with well-controlled RA managed on appropriate DMARD therapy do not require orthopaedic surgery. Surgery becomes relevant when a specific joint has already suffered irreversible damage that medication cannot repair, when a joint is significantly limiting daily function despite controlled systemic disease, or when a tendon or structural element has been destroyed. The need for surgery reflects the extent of prior joint damage, not a failure of current medical treatment.

7. Is it safe to have joint replacement surgery with rheumatoid arthritis?

Yes, with appropriate perioperative planning. Biologic DMARDs are typically paused around the time of surgery to reduce infection risk, and restarted once wound healing is confirmed. Corticosteroid doses are managed carefully. Bone quality is assessed. These factors are planned jointly between the rheumatologist and orthopaedic surgeon. In well-controlled RA with appropriate perioperative management, joint replacement outcomes are comparable to those in primary osteoarthritis.

8. Is rheumatoid arthritis treatment covered under Ayushman Bharat in Indore?

Certain investigations and orthopaedic surgical procedures for RA-related joint damage are covered under PM-JAY for eligible patients. Medical management through rheumatology has separate coverage pathways. Patients with Ayushman cards should discuss specific coverage applicable to their clinical situation at the time of consultation. The clinic’s experience with the Ayushman Bharat surgical process includes guiding patients through eligibility and pre-authorization for joint replacement and related procedures.